Zura Bio (ZURA) Competitors $1.23 -0.04 (-2.78%) As of 02:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZURA vs. TNGX, CRVS, SLDB, IMMP, CYRX, ATXS, TSVT, AVIR, GOSS, and RNACShould you be buying Zura Bio stock or one of its competitors? The main competitors of Zura Bio include Tango Therapeutics (TNGX), Corvus Pharmaceuticals (CRVS), Solid Biosciences (SLDB), Immutep (IMMP), Cryoport (CYRX), Astria Therapeutics (ATXS), 2seventy bio (TSVT), Atea Pharmaceuticals (AVIR), Gossamer Bio (GOSS), and Cartesian Therapeutics (RNAC). These companies are all part of the "pharmaceutical products" industry. Zura Bio vs. Its Competitors Tango Therapeutics Corvus Pharmaceuticals Solid Biosciences Immutep Cryoport Astria Therapeutics 2seventy bio Atea Pharmaceuticals Gossamer Bio Cartesian Therapeutics Tango Therapeutics (NASDAQ:TNGX) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, community ranking, dividends and valuation. Do institutionals and insiders believe in TNGX or ZURA? 79.0% of Tango Therapeutics shares are held by institutional investors. Comparatively, 61.1% of Zura Bio shares are held by institutional investors. 6.3% of Tango Therapeutics shares are held by company insiders. Comparatively, 14.2% of Zura Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings & valuation, TNGX or ZURA? Zura Bio has lower revenue, but higher earnings than Tango Therapeutics. Tango Therapeutics is trading at a lower price-to-earnings ratio than Zura Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTango Therapeutics$40.99M13.06-$101.74M-$1.22-4.05Zura BioN/AN/A-$69.24M-$0.70-1.75 Does the media refer more to TNGX or ZURA? In the previous week, Tango Therapeutics had 11 more articles in the media than Zura Bio. MarketBeat recorded 15 mentions for Tango Therapeutics and 4 mentions for Zura Bio. Zura Bio's average media sentiment score of 1.38 beat Tango Therapeutics' score of 1.11 indicating that Zura Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tango Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zura Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer TNGX or ZURA? Tango Therapeutics received 5 more outperform votes than Zura Bio when rated by MarketBeat users. However, 80.00% of users gave Zura Bio an outperform vote while only 74.36% of users gave Tango Therapeutics an outperform vote. CompanyUnderperformOutperformTango TherapeuticsOutperform Votes2974.36% Underperform Votes1025.64% Zura BioOutperform Votes2480.00% Underperform Votes620.00% Which has more risk & volatility, TNGX or ZURA? Tango Therapeutics has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Comparatively, Zura Bio has a beta of -0.12, suggesting that its share price is 112% less volatile than the S&P 500. Do analysts prefer TNGX or ZURA? Tango Therapeutics currently has a consensus price target of $12.20, suggesting a potential upside of 146.96%. Zura Bio has a consensus price target of $14.33, suggesting a potential upside of 1,070.07%. Given Zura Bio's stronger consensus rating and higher possible upside, analysts clearly believe Zura Bio is more favorable than Tango Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tango Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Zura Bio 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Is TNGX or ZURA more profitable? Zura Bio has a net margin of 0.00% compared to Tango Therapeutics' net margin of -284.42%. Zura Bio's return on equity of -37.36% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tango Therapeutics-284.42% -49.64% -32.00% Zura Bio N/A -37.36%-29.81% SummaryZura Bio beats Tango Therapeutics on 13 of the 18 factors compared between the two stocks. Get Zura Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZURA vs. The Competition Export to ExcelMetricZura BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$83.76M$3.11B$5.60B$8.63BDividend YieldN/A1.57%5.28%4.18%P/E Ratio-1.7533.0627.2520.01Price / SalesN/A469.00412.71157.94Price / CashN/A168.6838.2534.64Price / Book0.663.437.124.70Net Income-$69.24M-$72.35M$3.24B$248.05M7 Day Performance6.52%7.86%2.75%2.62%1 Month Performance-1.21%18.41%9.00%6.32%1 Year Performance-67.25%-16.84%31.41%13.78% Zura Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZURAZura Bio2.6762 of 5 stars$1.23-2.8%$14.33+1,070.1%-67.1%$83.76MN/A-1.753Positive NewsAnalyst RevisionTNGXTango Therapeutics2.1566 of 5 stars$2.54+14.4%$12.20+380.3%-31.5%$275.32M$40.99M-2.1590News CoveragePositive NewsAnalyst RevisionGap DownHigh Trading VolumeCRVSCorvus Pharmaceuticals2.6642 of 5 stars$4.03+6.6%$15.00+272.2%+110.3%$274.72MN/A-4.3330News CoverageAnalyst RevisionSLDBSolid Biosciences3.7726 of 5 stars$3.54+10.3%$14.90+320.9%-38.6%$274.40M$8.09M-1.16100Analyst RevisionHigh Trading VolumeIMMPImmutep1.4083 of 5 stars$1.86-1.1%$7.00+276.3%-31.7%$271.63M$5.14M0.002,021CYRXCryoport3.5271 of 5 stars$5.40-10.1%$11.00+103.7%-34.9%$270.74M$232.13M-1.601,020Positive NewsInsider TradeATXSAstria Therapeutics2.3806 of 5 stars$4.78+0.4%$30.00+527.6%-36.2%$269.76MN/A-2.2930News CoverageAnalyst RevisionTSVT2seventy bio1.2238 of 5 stars$5.00flat$4.25-15.0%N/A$266.15M$48.37M-2.69440AVIRAtea Pharmaceuticals3.3778 of 5 stars$3.10+4.4%$6.00+93.5%-19.1%$265.30MN/A-1.5070Positive NewsGOSSGossamer Bio3.8226 of 5 stars$1.16+4.1%$7.75+571.0%+152.7%$262.53M$124.59M-3.61180Positive NewsAnalyst RevisionRNACCartesian Therapeutics1.9234 of 5 stars$9.98+4.4%$43.00+330.9%-66.1%$259.02M$34.17M-0.1964Positive NewsAnalyst Revision Related Companies and Tools Related Companies TNGX Alternatives CRVS Alternatives SLDB Alternatives IMMP Alternatives CYRX Alternatives ATXS Alternatives TSVT Alternatives AVIR Alternatives GOSS Alternatives RNAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZURA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zura Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZURA Stock Free ZURA Stock Alerts